Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 4Uterine Cervical Neoplasms 2Oropharyngeal Neoplasms 2Hodgkin Disease 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Prostatic Neoplasms 1Pheochromocytoma 1Paraganglioma 1Ovarian Neoplasms 1Multiple Myeloma 1Mesothelioma 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Plasma Cell 1Glioma 1Disease 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Rituximab 11Cyclophosphamide 8ibrutinib 6acalabrutinib 6venetoclax 5fludarabine 4Whole-Body Irradiation 4zanubrutinib 3fludarabine phosphate 3Vincristine 3Peripheral Blood Stem Cell Transplantation 3Methotrexate 3Magnetic Resonance Spectroscopy 3Doxorubicin 3Cytarabine 3Cyclosporine 3CT-P10 3Bendamustine Hydrochloride 3merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Mycophenolic Acid 2Melphalan 2Etoposide 2Dexamethasone 2Calcium Dobesilate 2treosulfan 1palbociclib 1obinutuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Mantle-Cell × Fluorodeoxyglucose F18 × 30 days × Clear all
NCT05976763 2026-06-02

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
421 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡